Get the latest tech news
Demonstrating end-to-end scientific discovery with Robin: a multi-agent system
Today, we announce the first discovery made by Robin, our multi-agent system for automating scientific research. Read the preprint here: https://arxiv.org/abs/2505.13400 Robin code, data and full agent trajectories will be released Tuesday 5/27 FutureHouse's mission is to automate scientific discovery.
Today, we are excited to announce a significant breakthrough: by integrating these agents into a unified system named Robin, we've been able to automate the key intellectual steps of the entire scientific process and achieve our first AI-generated discovery. We applied Robin to identify ripasudil, a Rho-kinase (ROCK) inhibitor clinically used to treat glaucoma, as a novel therapeutic candidate for dry age-related macular degeneration (dAMD), a leading cause of irreversible blindness worldwide. Initial Hypothesis: Robin used Crow to conduct a broad literature review, and hypothesized that enhancing retinal pigment epithelium (RPE) phagocytosis could provide therapeutic benefit for dAMD.
Or read this on Hacker News
